Why Atina 11

Atina 11, based in London UK is partnering with pharmaceutical and biotechnology companies to co-develop and finance phase II and phase III clinical trial. The company uses its clinical development, regulatory expertise to obtain global approvals for a broad range of drugs and biologics. Our team with experts consulting the CROs to assure best quality of clinical research activities and study data collected. We are partnering with pharmaceutical and biotechnology companies in order to assure: 1/ innovative clinical trials management solutions, 2/we will guarantee high quality of the clinical trials data collected. 2/we fund pre-clinical phase, phase I, II, III studies that might be difficult to finance internally. 3/ we are acting globally 3/providing broadened pipeline.

As a full-service clinical trials expert structure, our capabilities span all phases of clinical development. Our project teams are created based on client and project needs and provide therapeutic expertise at all levels. We partner with clients across all areas of the clinical program, from protocol development to regulatory submission and this facilitates achieving the highest level of quality and efficiency in our work.

Our services are flexible and scalable. We are ready to partner with clients on developing an entire program or applying expert resources to a specific study or function.

Our expertise services include:

  • Protocol development
  • Protocol feasibility
  • Project management
  • Medical monitoring
  • Clinical monitoring
  • Data management
  • Rater training
  • Biostatistics
  • Medical Device & Digital Health
  • Regulatory affairs
  • Drug safety
  • Quality assurance
  • Drug and supply depots